« Back
Home /
Ribociclib succinate (LEE011 succinate)

Ribociclib succinate (LEE011 succinate)

Item no.	M4889-10mg
Manufacturer	AbMole
CASRN	1374639-75-4
Amount	10mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Head & Neck Cancer Nervous System Cancer
Type	Inhibitors
Specific against	other
Purity	0,9957
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Ribociclib succinate
Available
Target Information	CDK
Molecular Weight	552, 63
Solubility	DMSO ≥ 30 mg/mL
Bioactivity information	Ribociclib succinate (LEE011 succinate) is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M4889-10mg-safety-datasheet.pdf